Idiopathic Pulmonary Fibrosis | NEJM Skip to main content NEJM Group Follow Us Facebook
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …

This Review provides an updated approach to the diagnosis of idiopathic pulmonary fibrosis
(IPF), based on a systematic search of the medical literature and the expert opinion of …

The term interstitial lung abnormalities refers to specific CT findings that are potentially
compatible with interstitial lung disease in patients without clinical suspicion of the disease …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by
progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). It …

The clinical importance of interstitial lung abnormality (ILA) is increasingly recognized. In
July 2020, the Fleischner Society published a position paper about ILA. The purposes of this …

Importance Chronic lung diseases are a leading cause of morbidity and mortality. Unlike
chronic obstructive pulmonary disease, clinical outcomes associated with proportional …

Objectives To compare mortality risks in patients with rheumatoid arthritis-associated
interstitial lung disease (RA-ILD) and patients with RA without ILD. Design Matched cohort …

Rationale: Deep learning is a powerful tool that may allow for improved outcome prediction.
Objectives: To determine if deep learning, specifically convolutional neural network (CNN) …

Recruitment of immune cells to the site of inflammation by the chemokine CCL1 is important
in the pathology of inflammatory diseases. Here, we examined the role of CCL1 in …

Dr Athol Wells trained, graduated, and completed specialty training in New Zealand but
found his true home, personally and professionally, in the United Kingdom. He is a professor …